Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

David Dingli

Professor of Medicine

Mayo Clinic Minnesota

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (2)

Pedro Horna

Associate Professor

Mayo Clinic Rochester

UNITED STATES

View details

Yucai Wang

Mayo Clinic Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Dingli

Research Interests

Make your next move.

Explore related searches

Articles (20)

Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement

Subtype specific artificial intelligence modelling of cardiac amyloidosis using echocardiography and electrocardiography

Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma

Time‐Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal Hemoglobinuria

Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone

Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort study.

Switching patients with PNH from pegcetacoplan to iptacopan: a case series.

AL amyloidosis: a real-world experience with CAR T-cell therapy.

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma.

Cardiac Amyloidosis AI‐ECG Model is Useful in Predicting Outcomes in Multiple Myeloma Patients Without Amyloidosis Undergoing Autologous Stem Cell Transplant

Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular Thrombi

Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia

Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients.

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events.

The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma.

Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma.

Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma.

Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes.

Collaborators (2)

Pedro Horna

Yucai Wang

Make your next move.